T here can be no question that the desired immediate outcome of any cancer operation is the achievement of a complete resection as measured not only by the excision of all gross disease but by the finding of microscopic margins free of disease. Debulking procedures, with few exceptions, rarely lead to long-term survival, and en bloc resection with removal of regional lymph nodes remains the gold standard both from the standpoint of optimal therapy as well as staging.
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From the thoracic surgical perspective, we consider gastroesophageal junction (GEJ) lesions simply as part of the spectrum of esophageal cancer and choose the operative approach based primarily on the location of the tumor just as we have always done. This is relatively straightforward for distal esophageal lesions with minimal proximal gastric involvement (Siewert type I) where either transhiatal esophagectomy, left thoracotomy, or a left thoracoabdominal approach allows one to obtain generous proximal margins and remove both mediastinal as well as regional intraabdominal lymph nodes. Things get a little more complicated when the tumor straddles the GEJ (Siewert type II) or is subcardial in location with involvement of the distal esophagus (Siewert type III), and one can legitimately question whether these are esophageal or gastric in origin; and frequently, these are treated with a laparotomy and partial or total gastrectomy with excision of the distal esophagus from below.
Barbour and colleagues from Memorial Sloan-Kettering Cancer Center have now focused our attention squarely on the proximal esophageal margin and the importance of obtaining not only an "adequate" margin but an "optimal" margin. Utilizing their incredibly robust prospectively maintained database, they identified 505 patients treated by operation alone who underwent complete gross resection of a GEJ tumor (defined as a tumor within 5 cm proximal and distal of the GEJ). This "pure" group allowed them to ask and answer the question, "is a longer esophageal margin associated with improved survival?" The simple answer is "yes," but they have been able to take us well beyond this simple answer. While all of us have recognized the importance of achieving an R0 resection, data regarding the absolute length of the proximal resection margin have been lacking, and most of us simply have accepted any grossly negative margin and confirmed this microscopically on frozen section. In the current study, the Memorial group has convincingly demonstrated that a margin of at least 5 cm (in situ) is associated with improved survival in a select group of patients. Interestingly, the length of the margin did not correlate with improved survival in patients with T1 tumors but clearly did where the primary was T2 or greater. A gross proximal margin of at least 3.8 cm when measured ex vivo proved to be the cutoff point most predictive of improved overall survival. However, this survival advantage only held up if 6 or fewer lymph nodes proved to be positive for tumor. Siewert type III tumors tended to be resected with the shortest proximal margin (median, 2.5 cm) reflective of the fact that the majority of these (52%) were resected via a laparotomy with either partial or total gastrectomy and a limited esophagectomy.
Admittedly, the extent of the mediastinal dissection and thus the length of the proximal margin is limited with a laparotomy. Only 15 patients (10%) in the present series who underwent a gastrectomy had a proximal margin greater than 3.8 cm compared with 201 patients (57%) who had an esophagectomy, although the incidence of a positive esophageal margin did not differ between the 2 groups and the surgical approach itself was not an independent predictor of survival. So what is the takehome message here?
The present series clearly underscores the importance of an R0 resection but goes a step further in demonstrating the importance of at least a 3.8-cm margin when measured ex vivo, a length that translates into a 5-cm margin in situ. Thus, the surgical approach to a GEJ lesion needs to be planned to maximize achieving at least this length of the proximal (esophageal) margin. It has been and continues to be our preference to perform a transhiatal esophagectomy whenever possible. There can be no doubt about the length of the esophageal margin when the entire esophagus has been removed, and one can argue that total esophagectomy provides the best functional outcome. This also underscores the importance of the surgeon performing an upper endoscopy at the time of the operation to personally assess the extent of the tumor, a finding that may contraindicate the performance of a total esophagectomy because of the extent of gastric resection required. Transhiatal esophagectomy, although infrequently performed by the Memorial group, should be the preferred approach for Siewert type I lesions and for many type II lesions. However, this approach should include a complete lymph node dissection that encompasses both abdominal and mediastinal nodal stations. In the present series, at least 15 lymph nodes had to be present in the resected specimen to indicate that the resection had been performed with "curative" as opposed to palliative intent. For type II lesions where the surgeon judges that transposition of the gastric remnant into the neck will not be feasible and for true type III lesions, then either esophagogastrectomy via a left thoracoabdominal incision or a laparotomy and right thoracotomy should be the preferred approach. The determination as to whether to approach via the right or the left side depends largely on the extent of distal esophageal involvement assessed by endoscopy at the time of operation. If in order to achieve the desired 5-cm margin the anastomosis needs to be placed much above the level of the inferior pulmonary vein, the right chest is preferred since the anastomosis can easily be performed at the level of the azygous vein or even the apex of the chest depending on the length of available gastric remnant. Esophagogastrectomy via laparotomy alone should be reserved for pure gastric cancers without distal esophageal involvement where the length of the proximal margin is not a determinant of survival. This operation has limited usefulness when attempting to perform a "curative" resection for a tumor involving the GEJ no matter the Siewert type. Thus, the "complete" esophageal surgeon must be facile with multiple approaches, especially when dealing with GEJ tumors. One size clearly does not fit all, but the "bottom line" clearly revolves around the "top line," meaning the proximal margin. Whichever approach is chosen should allow for the removal of all gross disease with the regional lymph nodes and at least 5 cm of margin on the esophagus.
